Search

Taofiq A Solola

Examiner (ID: 14120, Phone: (571)272-0709 , Office: P/1625 )

Most Active Art Unit
1625
Art Unit(s)
1626, 1625, 1622, 1613
Total Applications
3196
Issued Applications
2336
Pending Applications
272
Abandoned Applications
640

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 13733031 [patent_doc_number] => 20180370983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-27 [patent_title] => OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES, THEIR PREPARATION AND USE [patent_app_type] => utility [patent_app_number] => 16/018924 [patent_app_country] => US [patent_app_date] => 2018-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14047 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16018924 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/018924
Oxabicycloheptanes and oxabicycloheptenes, their preparation and use Jun 25, 2018 Issued
Array ( [id] => 16310744 [patent_doc_number] => 20200289482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-17 [patent_title] => CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATORS FOR TREATING AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE [patent_app_type] => utility [patent_app_number] => 16/625419 [patent_app_country] => US [patent_app_date] => 2018-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14310 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16625419 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/625419
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATORS FOR TREATING AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE Jun 20, 2018 Abandoned
Array ( [id] => 14731293 [patent_doc_number] => 10385035 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-20 [patent_title] => Dinaphthothiophene compounds [patent_app_type] => utility [patent_app_number] => 16/013432 [patent_app_country] => US [patent_app_date] => 2018-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4668 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16013432 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/013432
Dinaphthothiophene compounds Jun 19, 2018 Issued
Array ( [id] => 17281672 [patent_doc_number] => 11198692 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-14 [patent_title] => Dihydro-pyrrolo-pyridine derivatives [patent_app_type] => utility [patent_app_number] => 16/625202 [patent_app_country] => US [patent_app_date] => 2018-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37076 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16625202 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/625202
Dihydro-pyrrolo-pyridine derivatives Jun 13, 2018 Issued
Array ( [id] => 13478903 [patent_doc_number] => 20180290994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-11 [patent_title] => OXIDATION PROCESS TO PRODUCE A PURIFIED CARBOXYLIC ACID PRODUCT VIA SOLVENT DISPLACEMENT AND POST OXIDATION [patent_app_type] => utility [patent_app_number] => 16/004549 [patent_app_country] => US [patent_app_date] => 2018-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12127 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16004549 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/004549
OXIDATION PROCESS TO PRODUCE A PURIFIED CARBOXYLIC ACID PRODUCT VIA SOLVENT DISPLACEMENT AND POST OXIDATION Jun 10, 2018 Abandoned
Array ( [id] => 15338731 [patent_doc_number] => 10525019 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-07 [patent_title] => Methods of treating diseases associated with high-fat diet and vitamin a deficiency using retinoic acid receptor agonists [patent_app_type] => utility [patent_app_number] => 16/000003 [patent_app_country] => US [patent_app_date] => 2018-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 24 [patent_no_of_words] => 17922 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16000003 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/000003
Methods of treating diseases associated with high-fat diet and vitamin a deficiency using retinoic acid receptor agonists Jun 4, 2018 Issued
Array ( [id] => 16998315 [patent_doc_number] => 11077097 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-03 [patent_title] => Use of aromatic ring drug in inhibiting key transcription factor of malignant melanoma [patent_app_type] => utility [patent_app_number] => 16/627144 [patent_app_country] => US [patent_app_date] => 2018-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 4065 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 269 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16627144 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/627144
Use of aromatic ring drug in inhibiting key transcription factor of malignant melanoma Jun 3, 2018 Issued
Array ( [id] => 14852057 [patent_doc_number] => 10414740 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-09-17 [patent_title] => Glutaminase inhibitors and method of use [patent_app_type] => utility [patent_app_number] => 15/996723 [patent_app_country] => US [patent_app_date] => 2018-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27041 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15996723 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/996723
Glutaminase inhibitors and method of use Jun 3, 2018 Issued
Array ( [id] => 13457649 [patent_doc_number] => 20180280367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-04 [patent_title] => USE OF ANTHELMINTIC AGENTS AGAINST DIROFILARIA IMMITIS [patent_app_type] => utility [patent_app_number] => 15/996951 [patent_app_country] => US [patent_app_date] => 2018-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15066 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15996951 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/996951
USE OF ANTHELMINTIC AGENTS AGAINST DIROFILARIA IMMITIS Jun 3, 2018 Abandoned
Array ( [id] => 14227129 [patent_doc_number] => 20190125737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-02 [patent_title] => MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/994005 [patent_app_country] => US [patent_app_date] => 2018-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21064 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15994005 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/994005
MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF May 30, 2018 Abandoned
Array ( [id] => 13504625 [patent_doc_number] => 20180303855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-25 [patent_title] => COMPOSITION AND METHODS OF USE OF SMALL MOLECULES AS BINDING LIGANDS FOR THE MODULATION OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9(PCSK9) PROTEIN ACTIVITY [patent_app_type] => utility [patent_app_number] => 15/989360 [patent_app_country] => US [patent_app_date] => 2018-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16458 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15989360 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/989360
Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity May 24, 2018 Issued
Array ( [id] => 15678343 [patent_doc_number] => 20200093835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-26 [patent_title] => METHODS OF TREATING VESTIBULAR SCHWANNOMA [patent_app_type] => utility [patent_app_number] => 16/612317 [patent_app_country] => US [patent_app_date] => 2018-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11154 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16612317 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/612317
METHODS OF TREATING VESTIBULAR SCHWANNOMA May 22, 2018 Abandoned
Array ( [id] => 15990303 [patent_doc_number] => 20200171022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-04 [patent_title] => FLT3 INHIBITORS FOR IMPROVING PAIN TREATMENTS BY OPIOIDS [patent_app_type] => utility [patent_app_number] => 16/613859 [patent_app_country] => US [patent_app_date] => 2018-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11647 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16613859 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/613859
FLT3 INHIBITORS FOR IMPROVING PAIN TREATMENTS BY OPIOIDS May 16, 2018 Abandoned
Array ( [id] => 16086795 [patent_doc_number] => 20200197384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-25 [patent_title] => TREATMENT OF HEPATOCELLULAR CARCINOMA [patent_app_type] => utility [patent_app_number] => 16/609895 [patent_app_country] => US [patent_app_date] => 2018-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32917 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609895 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/609895
TREATMENT OF HEPATOCELLULAR CARCINOMA May 14, 2018 Abandoned
Array ( [id] => 13618387 [patent_doc_number] => 20180360745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-20 [patent_title] => METHOD OF TREATING DISEASE [patent_app_type] => utility [patent_app_number] => 15/978742 [patent_app_country] => US [patent_app_date] => 2018-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21632 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15978742 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/978742
Method of treating disease May 13, 2018 Issued
Array ( [id] => 15962947 [patent_doc_number] => 20200165225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-28 [patent_title] => BACE1 INHIBITORS FOR TREATMENT OF ALZHEIMER'S DISEASE [patent_app_type] => utility [patent_app_number] => 16/626717 [patent_app_country] => US [patent_app_date] => 2018-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8101 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 242 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16626717 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/626717
BACE1 INHIBITORS FOR TREATMENT OF ALZHEIMER'S DISEASE May 7, 2018 Abandoned
Array ( [id] => 14551141 [patent_doc_number] => 10344011 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2019-07-09 [patent_title] => Furan-2,5-dicarboxylic acid purge process [patent_app_type] => utility [patent_app_number] => 15/971106 [patent_app_country] => US [patent_app_date] => 2018-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8171 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 318 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15971106 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/971106
Furan-2,5-dicarboxylic acid purge process May 3, 2018 Issued
Array ( [id] => 17420071 [patent_doc_number] => 11253500 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-22 [patent_title] => Sanfetrinem or a salt or ester thereof for use in treating mycobacterial infection [patent_app_type] => utility [patent_app_number] => 16/611908 [patent_app_country] => US [patent_app_date] => 2018-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8096 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16611908 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/611908
Sanfetrinem or a salt or ester thereof for use in treating mycobacterial infection May 3, 2018 Issued
Array ( [id] => 16008983 [patent_doc_number] => 20200179334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-11 [patent_title] => METHODS AND COMPOSITIONS FOR TREATING ENDOMETRIOSIS AND ENDOMETRIOSIS ASSOCIATED SYMPTOMS [patent_app_type] => utility [patent_app_number] => 16/609413 [patent_app_country] => US [patent_app_date] => 2018-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15074 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609413 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/609413
METHODS AND COMPOSITIONS FOR TREATING ENDOMETRIOSIS AND ENDOMETRIOSIS ASSOCIATED SYMPTOMS May 2, 2018 Abandoned
Array ( [id] => 14005435 [patent_doc_number] => 10221153 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-03-05 [patent_title] => Dibenzothiophene compounds [patent_app_type] => utility [patent_app_number] => 15/970584 [patent_app_country] => US [patent_app_date] => 2018-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 15 [patent_no_of_words] => 10266 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15970584 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/970584
Dibenzothiophene compounds May 2, 2018 Issued
Menu